Page 24 - Zenabis Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Hexo to buy 48North in deal valued at $50 million - Medicine Hat NewsMedicine Hat News
medicinehatnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicinehatnews.com Daily Mail and Mail on Sunday newspapers.
Most actively traded companies on the Toronto Stock Exchange
680news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 680news.com Daily Mail and Mail on Sunday newspapers.
Hexo to buy 48North in deal valued at $50M - Article
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Zenabis receives Malta license for medical cannabis production
Zenabis Global’s Maltese joint venture ZenPharm obtains Maltese licence to produce cannabis for medicinal and research purposes,
15 May 2021, 12:52pm
by Matthew Vella
ZenPharm is the second licencee to be given the go-ahead to a medical cannabis licence in Malta
Zenabis Global’s Maltese joint venture ZenPharm has received its Maltese licence to produce cannabis for medicinal and research purposes, after a two-year process by the Malta Medicines Authority.
The receipt of the Medicinal Cannabis License follows on the earlier European Union Good Manufacturing Practices certification issued by Malta Medicines Authority in January 2021.
Canadian cannabis company, Zenabis Global Inc. (TSX: ZENA) (OTC: ZBISF) released Wednesday its fourth-quarter and full-year financial results with full-year revenue of $59.3 million.
Full-Year Highlights
Consolidated net revenue jumped 95% from the prior year.
Consolidated adjusted EBITDA came in. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to: